StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) stock

SAENNasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.58−0.02 (-3.83%)

Close on Nov 17, 2026Market cap $13.52MP/E –Yield –

Genenta Science S.p.A. price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Genenta Science S.p.A.

Genenta Science S.p.A. has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Genenta Science S.p.A. figures

See a number that looks wrong?